ישראל - עברית - Ministry of Health

j-c health care ltd - decitabine - אבקה להכנת תמיסה מרוכזת לעירוי - decitabine 50 mg/vial - decitabine - decitabine - - dacogen is indicated for treatment of patients with myelodysplastic syndromes (mds) including prevviously treated and untreated, de novo and secondary mds of all french-american- british subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia ) and intermediate- 1, intermediate- 2, and high-risk international prognostic scoring system groups.- dacogen is indicated for the treatment of adult patients aged 65 years and above with newly diagnosed de novo or secondary acute myeloid leukaemia (aml), according to the world health organisation (who) classification, who are not candidates for standard induction chemotherapy

ישראל - עברית - Ministry of Health

novartis israel ltd - canakinumab - אבקה להכנת תמיסה לזריקה - canakinumab 150 mg / 1 ml - canakinumab - canakinumab - cryopyrin - associated periodic syndromes (caps) in adults, adolescents and children aged 2 years and older with body weight above 7.5 kg, including : - mucle - wells syndrome (mws), - neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca), - severe forms of familial cold autoinflammatory syndrome (fcas) / familial cold urticaria (fcu) presenting with signs and symptoms beyond cold-induced urticarial skin rash.gouty arthritis:ilaris is indicated for the symptomatic treatment of adults patients with frequent gouty arthritis attacks (at least 3 attacks in the previous 12 months) in whom non-steroidal anti-inflammatory drugs (nsaids) and colchicine are contraindicated, are not tolerated, or do not provide an adequate response, and in whom repeated courses of corticosteroids are not appropriate.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - diltiazem hydrochloride - קפסולות - שחרור מבוקר - diltiazem hydrochloride 120 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - diltiazem hydrochloride - קפסולות - שחרור מבוקר - diltiazem hydrochloride 180 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - diltiazem hydrochloride - קפסולות - שחרור מבוקר - diltiazem hydrochloride 240 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.

ישראל - עברית - Ministry of Health

amgen europe b.v. - panitumumab - תרכיז להכנת תמיסה לאינפוזיה - panitumumab 20 mg / 1 ml - panitumumab - in combination with chemotherapy for the treatment of unresectable, advanced or recurrent colorectal cancer (mcrc) with wild-type kras.monotherapy for the treatment of patients with metastatic colorectal carcinoma with wild-type kras after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.

ישראל - עברית - Ministry of Health

novartis israel ltd - canakinumab - תמיסה להזרקה - canakinumab 150 mg / 1 ml - canakinumab

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - טבליות בשחרור איטי - verapamil hydrochloride 240 mg - verapamil

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - טבליות עם שחרור מושהה - verapamil hydrochloride 180 mg - verapamil

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - טבליה - verapamil hydrochloride 120 mg - verapamil